EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Ruthenium( ii )-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductase

Sara Pagliaricci, Noemi Pagliaricci, Alessia Tombesi, Claudio Pettinari, Massimiliano Cuccioloni, Helena Juricic, Agustín Galindo, Farzaneh Fadaei-Tirani, Riccardo Pettinari, Fabio Marchetti

Dalton Transactions · 2025

DOI: 10.1039/d5dt01240f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2025. Verfasst von Sara Pagliaricci und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Camerino, via Madonna delle Carceri, 62032 Camerino, MC, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coordination Complexes, Ruthenium, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The synthesis of new conjugated bisdemethoxycurcumin ligands, each incorporating a distinct acyl substituent—cyclic, aliphatic, heteroaromatic, or branched—in place of the native hydroxyl groups, has been reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCoordination ComplexesRutheniumProteasome Endopeptidase ComplexDiarylheptanoidsHydroxymethylglutaryl CoA ReductasesProteasome InhibitorsHumansDrug Screening Assays, AntitumorCell Line, TumorCell ProliferationDensity Functional Theory

Substanzen

Antineoplastic AgentsCoordination ComplexesRutheniumProteasome Endopeptidase ComplexDiarylheptanoidsHydroxymethylglutaryl CoA ReductasesbisdemethoxycurcuminProteasome Inhibitors

Autor:innen und Institutionen

  • School of Pharmacy, University of Camerino, via Madonna delle Carceri, 62032 Camerino, MC, Italy.
  • School of Biosciences and Veterinary Medicine, University of Camerino, via Madonna delle Carceri, 62032 Camerino, MC, Italy.
  • Departamento de Química Inorgánica, Facultad de Química, Universidad de Sevilla, Aptdo 1203, 41071 Sevilla, Spain.
  • Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • School of Science and Technology, University of Camerino, via Madonna delle Carceri, 62032 Camerino, MC, Italy.

Förderung

  • European Commission

Zitieren

APA

Pagliaricci, S., Pagliaricci, N., Tombesi, A., Pettinari, C., Cuccioloni, M., Juricic, H., Galindo, A., Fadaei-Tirani, F., Pettinari, R., & Marchetti, F. (2025). Ruthenium( ii )-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductase. Dalton Transactions. https://doi.org/10.1039/d5dt01240f

Vancouver

Pagliaricci S, Pagliaricci N, Tombesi A, Pettinari C, Cuccioloni M, Juricic H, et al. Ruthenium( ii )-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductase. Dalton Transactions. 2025. doi:10.1039/d5dt01240f

BibTeX
@article{Pagliaricci2025,
  author = {Pagliaricci, Sara and Pagliaricci, Noemi and Tombesi, Alessia and Pettinari, Claudio and Cuccioloni, Massimiliano and Juricic, Helena and Galindo, Agustín and Fadaei-Tirani, Farzaneh and Pettinari, Riccardo and Marchetti, Fabio},
  title = {Ruthenium( ii )-bisdemethoxycurcumin conjugate complexes as potent antitumour agents through simultaneous inhibition of 20S proteasome and HMG-CoA reductase},
  journal = {Dalton Transactions},
  year = {2025},
  doi = {10.1039/d5dt01240f}
}
Kostenlos starten →